Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Cash from Investing Activities (2024 - 2025)

Updated

Niki BioSolutions (NIKI) recorded Cash from Investing Activities of -$6,938 in FY2025.

Analysis

Niki BioSolutions (NIKI) Cash from Investing Activities (2024 - 2025) Analysis & Trends

Starting with FY2017, Niki BioSolutions' Cash from Investing Activities history includes 9 years.

  • The FY2025 figure is the lowest annual Cash from Investing Activities since FY2019.
  • Per Business Quant data, NIKI's Cash from Investing Activities was $58,621 in FY2024 (-90.6%), $624,767 in FY2023 (-74.4%), $2.44 million in FY2022 (-85.2%) and $16.51 million in FY2021 (+796.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Niki BioSolutions 2.51 Mn 2.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -6,938.00
May 31, 2024 -59,899.00
API Access

Niki BioSolutions Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NIKI&period=max&api_key=YOUR_API_KEY